CVS Health Corp. closed $34.74 short of its 52-week high ($80.75), which the company reached on March 28th.

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging margins.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of ...

In a report released today, Charles Rhyee from TD Cowen maintained a Hold rating on CVS Health (CVS – Research Report), with a price target of ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.BYxs733P.js ...

CVS Health has announced that all commercial prescriptions dispensed through its pharmacies will be now contracted through the company's CostVantage reimbursement model. The model ...

The community was given a bit of a shock recently when CVS announced that it would be leaving its downtown Cumberland location on Jan. 30.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...

The Consumer Financial Protection Bureau has estimated that this could boost the credit scores of people with medical debt by an average of 20 points, potentially improving their access to housing and ...

Shares of CVS Health Corp. CVS inched 0.11% higher to $45.82 Monday, on what proved to be an all-around mixed trading session ...

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $68.07, accompanied by ...

United Natural Foods Inc., buoyed by the turnaround plan it began in 2023, saw the biggest lift in value last year among ...